Catalent Issues Initial Public Offering
Catalent Inc. has issued an Initial Public Offering and is now a publicly traded company on the New York Stock Exchange. Our new trading ticker on the Big Board is CTLT!
Every molecule has a challenge. We have a solution.
Discover innovative solutions to improve the value of your treatments at every stage.
Find the best oral drug delivery technology options for your challenging molecule.
Learn more about our tailored solutions for Consumer Health, Animal Health & Biologics.